JORDAN BROTZ: Open Payments
NPI 1104574334 · HAYTI, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 39 payments from 15 companies in 2025. Trend: 2023 $36 · 2024 $262 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $214 |
| Alkermes, Inc. | 13 | $194 |
| Lundbeck LLC | 3 | $66 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Dexcom, Inc. | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Grifols USA, LLC | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Philips North America LLC | 1 | $17 |
Products named: REXULTI, ARISTADA, INVEGA SUSTENNA, Dexcom G6 Transmitter, INGREZZA, Prolastin-C Liquid, VOQUEZNA, FARXIGA.
Industry payments across MO — which companies pay providers there.
